Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 166.39
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2016, vol. 25, nr 1, January-February, p. 191–197

doi: 10.17219/acem/32065

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Prevention of Iatrogenic Anemia in Critical and Neonatal Care

Natalia Jakacka1,A,B,E,F, Emilian Snarski1,A,B,D,E,F, Selamawit Mekuria1,A,B,D,E,F

1 Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland

Abstract

Iatrogenic anemia caused by diagnostic blood sampling is a common problem in the intensive care unit, where continuous monitoring of blood parameters is very often required. Cumulative blood loss associated with phlebotomy along with other factors render this group of patients particularly susceptible to anemia. As it has been proven that anemia in this group of patients leads to inferior outcomes, packed red blood cell transfusions are used to alleviate possible threats associated with low hemoglobin concentration. However, the use of blood components is a procedure conferring a set of risks to the patients despite improvements in safety. Iatrogenic blood loss has also gained particular attention in neonatal care, where cumulative blood loss due to samples taken during the first week of life could easily equal or exceed circulating blood volume. This review summarizes the current knowledge on the causes of iatrogenic anemia and discusses the most common preventive measures taken to reduce diagnostic blood loss and the requirement for blood component transfusions in the aforementioned clinical situations.

Key words

intensive care unit, anemia, iatrogenic disease, neonatal intensive care, blood transfusion

References (29)

  1. Papa F, Rongioletti M, Ventura MD, Di Turi F, Cortesi M, Pasqualetti P, Majolini MB, Collegiani V, Cicchese M, Notarmuzi ML, Agostino R, Liumbruno GM: Blood cell counting in neonates: a comparison between a low volume micromethod and the standard laboratory method. Blood Transfus 2011, 9, 400–406.
  2. Verghese A: Culture shock – patient as icon, icon as patient. N Engl J Med 2008, 25, 2748–2751.
  3. Woodhouse S: Complication of critical care: lab testing and iatrogenic anemia. MLO Med Lab Obs 2001, 33, 28–31.
  4. Tavendiranathan P, Bagai A, Ebidia A, Detsky AS, Choudhry NK: Do blood tests cause anemia in hospitalized patients? The effect of diagnostic phlebotomy on hemoglobin and hematocrit levels. J Gen Intern Med 2005, 20, 520–524.
  5. Nexø E, Christensen NC, Olesen H: Volume of blood removed for analytical purposes during hospitalization of low-birthweight infants. Clin Chem 1981, 27, 759–761.
  6. Bell EF: When to transfuse preterm babies. Arc Dis Child Fetal Neonatal Ed 2008, 93, 469–473.
  7. Widness JA: Treatment and prevention of neonatal anaemia. Neoreviews 2008, 9, 526–533.
  8. Bateman ST, Lacroix J, Boven K, Forbes P, Barton R, Thomas NJ, Jacobs B, Markovitz B, Goldstein B, Hanson JH, Li HA, Randolph AG: Pediatric Acute Lung Injury and Sepsis Investigators Network Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med 2008, 178, 26–33.
  9. Valentine SL, Bateman ST: Identifying factors to minimize phlebotomy-induced blood loss in the pediatric intensive care unit. Pediatr Crit Care Med 2012, 13, 22–27.
  10. Demir AY, van Solinge WW, Kemperman H: Handling of and direct sampling from primary Barcode-labeled pediatric tubes on Vitros Clinical Chemistry analyzers integrated into an enGen Work Cell. Clin Chem 2005, 51, 920–921.
  11. Briggs C, Guthrie D, Hyde K, Mackie I, Parker N, Popek M, Porter N, Stephens C: British Committee for Standards in Haematology General Haematology Task Force: Guidelines for point-of-care testing: haematology. Br J Haematol 2008, 142, 904–915.
  12. Briggs C, Carter J, Lee SH, Sandhaus L, Simon-Lopez R, Vives Corrons JL: International Council for Standardization in Haematology: ICSH Guideline for worldwide point-of-care testing in haematology with special reference to the complete blood count. Int J Lab Hematol 2008, 30, 105–116.
  13. St. Louis P: Status of point-of-care testing: promise, realities, and possibilities. Clin Biochem 2000, 33, 427–440.
  14. Hitt E: Smaller blood tubes reduce the amount of blood drawn for lab test without affecting results. March 2011: http://www.medscape.com/viewarticle/718472, referred on 8th April 2012.
  15. Madan A, Kumar R, Adams MM, Benitz WE, Geaghan SM, Widness JA: Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 2005, 25, 21–25.
  16. Scalise D: Poised for growth. Point-of-care testing. Hosp Health Netw 2006, 77–83.
  17. Rabe H, Stupp N, Ozgün M, Harms E, Jungmann H: Measurement of transcutaneous hemoglobin concentration by noninvasive white-light spectroscopy in infants. Pediatrics 2005, 116, 841–843.
  18. Rabe H, Alvarez RF, Whitfield T, Lawson F, Jungmann H: Spectroscopic noninvasive measurement of hemoglobin compared with capillary and venous values in neonates. Neonatology 2010, 98, 1–5.
  19. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ: The CRIT Study: Anemia and blood transfusion in the critically ill – current clinical practice in the United States. Crit Care Med 2004, 32, 39–52.
  20. Pohlman AS, Carven JH, Lindsay K: Conserving blood in the intensive care unit. Crit Care Nurse 2001, Suppl 1–14, quiz 16.
  21. Studnicki J, Bradham DD, Marshburn J, Foulis PR, Straumfjord JV: A feedback system for reducing excessive laboratory tests. Arch Pathol Lab Med 1993, 117, 35–39.
  22. Merlani P, Garnerin P, Diby M, Ferring M, Ricou B: Quality improvement report: Linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care. BMJ 2001, 323, 620–624.
  23. Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL: Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997, 23, 159–162.
  24. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, Allard S, Thomas D, Walsh T: British Committee for Standards in Haematology: Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol 2013, 160, 445–464.
  25. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340, 409–417.
  26. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettilä V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Müller RG, Møller MH, Steensen M, Tjäder I, Kilsand K, Odeberg-Wernerman S, Sjøbø B, Bundgaard H, Thyø MA, Lodahl D, Mærkedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A, TRISS Trial Group
  27. Van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28, 2773–2778.
  28. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ: Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 1999, 27, 2346–2350.
  29. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O: Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 1997, 77, 176–185.